Nifty
Sensex
:
:
8469.40
28898.36
385.60 (4.77%)
1307.41 (4.74%)

Pharmaceuticals & Drugs

Rating :
80/99

BSE: 500420 | NSE: TORNTPHARM

2077.00
03-Apr-2020
  • Open
  • High
  • Low
  • Previous Close
  •  1979.00
  •  2113.00
  •  1950.00
  •  1959.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1013029
  •  20887.41
  •  2287.25
  •  1452.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 35,146.34
  • 62.87
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 40,368.40
  • 0.82%
  • 6.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 1.04%
  • 6.52%
  • FII
  • DII
  • Others
  • 8.48%
  • 11.54%
  • 1.17%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.88
  • 10.52
  • 9.68

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.77
  • 14.22
  • 7.56

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.56
  • -10.29
  • -22.40

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.18
  • 27.37
  • 38.06

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.77
  • 6.15
  • 5.59

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.19
  • 14.84
  • 16.59

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Net Sales
1,966.00
2,051.00
-4.14%
2,005.00
1,894.00
5.86%
2,022.00
1,872.00
8.01%
1,856.00
1,708.00
8.67%
Expenses
1,426.00
1,490.00
-4.30%
1,464.00
1,421.00
3.03%
1,481.00
1,395.00
6.16%
1,383.00
1,344.00
2.90%
EBITDA
540.00
561.00
-3.74%
541.00
473.00
14.38%
541.00
477.00
13.42%
473.00
364.00
29.95%
EBIDTM
27.47%
27.35%
26.98%
24.97%
26.76%
25.48%
25.48%
21.31%
Other Income
53.00
3.00
1,666.67%
34.00
10.00
240.00%
20.00
27.00
-25.93%
17.00
42.00
-59.52%
Interest
111.00
133.00
-16.54%
116.00
126.00
-7.94%
122.00
122.00
0.00%
123.00
121.00
1.65%
Depreciation
163.00
156.00
4.49%
163.00
152.00
7.24%
160.00
150.00
6.67%
160.00
151.00
5.96%
PBT
319.00
275.00
16.00%
296.00
205.00
44.39%
279.00
232.00
20.26%
-150.00
134.00
-
Tax
68.00
29.00
134.48%
52.00
26.00
100.00%
63.00
69.00
-8.70%
2.00
-94.00
-
PAT
251.00
246.00
2.03%
244.00
179.00
36.31%
216.00
163.00
32.52%
-152.00
228.00
-
PATM
12.77%
11.99%
12.17%
9.45%
10.68%
8.71%
-8.19%
13.35%
EPS
14.83
14.54
1.99%
14.42
10.58
36.29%
12.76
9.63
32.50%
-8.98
13.47
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
7,849.00
7,672.80
5,949.83
5,815.69
6,686.93
4,653.45
4,184.72
3,211.14
2,695.92
2,197.79
1,916.04
Net Sales Growth
4.31%
28.96%
2.31%
-13.03%
43.70%
11.20%
30.32%
19.11%
22.67%
14.70%
 
Cost Of Goods Sold
2,172.00
2,041.26
1,535.17
1,629.66
1,452.21
1,280.96
1,107.58
807.98
774.38
616.64
516.71
Gross Profit
5,677.00
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
3,077.14
2,403.16
1,921.54
1,581.16
1,399.32
GP Margin
72.33%
73.40%
74.20%
71.98%
78.28%
72.47%
73.53%
74.84%
71.28%
71.94%
73.03%
Total Expenditure
5,754.00
5,689.74
4,600.58
4,438.42
3,957.13
3,633.29
3,233.24
2,518.92
2,203.54
1,810.01
1,495.26
Power & Fuel Cost
-
132.46
118.77
107.98
92.59
97.41
71.88
62.80
56.97
42.53
27.40
% Of Sales
-
1.73%
2.00%
1.86%
1.38%
2.09%
1.72%
1.96%
2.11%
1.94%
1.43%
Employee Cost
-
1,403.79
1,135.25
993.41
842.35
841.81
741.10
623.29
531.80
440.44
308.33
% Of Sales
-
18.30%
19.08%
17.08%
12.60%
18.09%
17.71%
19.41%
19.73%
20.04%
16.09%
Manufacturing Exp.
-
511.16
457.58
502.16
353.45
345.98
320.78
278.15
225.27
210.89
223.19
% Of Sales
-
6.66%
7.69%
8.63%
5.29%
7.43%
7.67%
8.66%
8.36%
9.60%
11.65%
General & Admin Exp.
-
811.58
677.71
578.05
637.92
477.59
399.07
324.55
255.89
206.88
177.67
% Of Sales
-
10.58%
11.39%
9.94%
9.54%
10.26%
9.54%
10.11%
9.49%
9.41%
9.27%
Selling & Distn. Exp.
-
738.03
641.30
567.70
547.05
574.40
461.53
393.07
322.29
274.61
225.10
% Of Sales
-
9.62%
10.78%
9.76%
8.18%
12.34%
11.03%
12.24%
11.95%
12.49%
11.75%
Miscellaneous Exp.
-
51.46
34.80
59.46
31.56
15.14
131.30
29.08
36.94
18.03
225.10
% Of Sales
-
0.67%
0.58%
1.02%
0.47%
0.33%
3.14%
0.91%
1.37%
0.82%
0.88%
EBITDA
2,095.00
1,983.06
1,349.25
1,377.27
2,729.80
1,020.16
951.48
692.22
492.38
387.78
420.78
EBITDA Margin
26.69%
25.85%
22.68%
23.68%
40.82%
21.92%
22.74%
21.56%
18.26%
17.64%
21.96%
Other Income
124.00
57.05
298.84
223.30
228.80
285.55
38.13
43.36
52.78
56.23
21.63
Interest
472.00
503.75
308.48
205.56
183.98
175.16
58.63
33.80
39.45
39.13
29.10
Depreciation
646.00
617.69
408.60
306.92
237.55
190.74
87.00
82.69
81.73
62.56
66.09
PBT
744.00
918.67
931.01
1,088.09
2,537.07
939.81
843.98
619.09
423.98
342.33
347.22
Tax
185.00
125.35
252.87
154.51
610.17
188.84
180.07
146.69
72.32
72.17
116.02
Tax Rate
24.87%
22.32%
27.16%
14.20%
26.04%
20.09%
21.34%
25.22%
20.17%
21.08%
33.41%
PAT
559.00
436.28
678.11
933.55
1,733.24
750.94
663.88
432.76
284.04
270.17
231.20
PAT before Minority Interest
559.00
436.31
678.14
933.58
1,733.27
750.97
663.91
434.91
286.30
270.17
231.20
Minority Interest
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-0.03
-2.15
-2.26
0.00
0.00
PAT Margin
7.12%
5.69%
11.40%
16.05%
25.92%
16.14%
15.86%
13.48%
10.54%
12.29%
12.07%
PAT Growth
-31.50%
-35.66%
-27.36%
-46.14%
130.81%
13.11%
53.41%
52.36%
5.13%
16.86%
 
Unadjusted EPS
33.03
25.78
40.07
55.17
102.42
44.38
39.23
25.58
33.57
31.93
27.32

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
1,421.93
1,193.83
1,022.40
830.98
Share Capital
84.62
84.62
84.62
84.62
84.62
84.62
42.31
42.31
42.31
42.31
Total Reserves
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
1,379.62
1,151.52
980.10
788.67
Non-Current Liabilities
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
926.76
619.81
487.73
397.60
572.29
Secured Loans
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
730.72
403.19
223.83
170.59
364.64
Unsecured Loans
3.11
6.15
11.26
10.62
13.62
13.74
51.35
98.22
122.45
157.75
Long Term Provisions
288.52
286.66
263.04
246.36
207.49
190.43
129.51
110.45
56.14
0.00
Current Liabilities
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
1,710.65
1,362.84
1,114.09
549.59
Trade Payables
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
1,067.74
863.47
615.00
383.60
Other Current Liabilities
1,641.26
1,151.68
687.14
822.28
446.15
371.63
275.83
291.00
312.85
43.39
Short Term Borrowings
934.11
1,625.60
0.00
3.32
319.07
210.43
124.62
138.12
99.57
0.00
Short Term Provisions
493.21
376.65
301.80
199.66
230.81
163.39
242.46
70.25
86.66
122.60
Total Liabilities
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69
1,952.86
Net Block
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
875.34
819.82
796.87
635.55
541.15
Gross Block
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
1,278.15
1,199.64
964.28
812.94
Accumulated Depreciation
2,187.72
1,594.80
1,221.36
934.45
710.27
544.70
458.33
402.77
328.73
271.79
Non Current Assets
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
1,191.87
1,060.78
941.27
670.02
Capital Work in Progress
617.12
646.94
519.49
1,041.58
678.33
534.11
285.28
113.55
179.88
109.82
Non Current Investment
2.09
0.09
0.09
0.09
0.06
0.03
0.03
37.52
20.00
19.05
Long Term Loans & Adv.
150.58
130.96
182.32
99.66
206.92
129.47
62.84
61.37
59.51
0.00
Other Non Current Assets
196.03
72.22
122.40
85.25
50.28
60.74
23.90
46.25
46.34
0.00
Current Assets
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
2,560.89
1,987.12
1,594.42
1,282.84
Current Investments
351.35
492.27
803.55
779.59
297.59
185.63
60.44
86.52
125.99
122.13
Inventories
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
923.86
531.56
504.83
323.63
Sundry Debtors
1,435.71
1,253.45
950.89
1,445.09
1,587.26
1,099.42
687.82
522.80
340.40
298.16
Cash & Bank
816.04
867.23
893.72
647.03
567.36
769.42
626.97
674.28
478.80
388.33
Other Current Assets
499.29
587.77
589.54
369.16
532.03
343.95
261.80
171.96
144.41
150.60
Short Term Loans & Adv.
93.46
95.39
82.62
90.18
109.09
84.95
75.95
56.46
49.28
109.06
Net Current Assets
-127.78
60.24
2,141.21
1,403.55
1,227.66
1,229.90
850.24
624.28
480.33
733.26
Total Assets
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
3,047.90
2,535.69
1,952.86

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
1,798.08
894.15
1,008.84
2,742.12
810.20
599.42
153.48
499.13
395.01
287.00
PBT
561.66
931.01
1,088.09
2,343.44
939.81
843.98
581.60
358.62
342.33
347.22
Adjustment
1,418.19
606.92
430.27
552.44
337.96
136.79
126.13
79.64
74.80
80.63
Changes in Working Capital
99.39
-360.16
-125.21
423.58
-409.38
-119.68
-421.75
143.58
61.88
-74.82
Cash after chg. in Working capital
2,079.24
1,177.77
1,393.15
3,319.46
868.39
861.09
285.98
581.84
479.01
353.04
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-281.16
-283.62
-384.31
-577.34
-58.19
-261.67
-132.50
-82.71
-84.00
-66.04
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
-241.70
-136.97
-232.60
-128.71
Net Fixed Assets
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
-455.28
-84.67
-52.13
-152.17
Net Investments
138.83
310.79
-17.69
-484.32
-111.97
-131.60
287.55
-47.29
-199.04
13.48
Others
230.63
-772.52
-177.21
117.89
216.24
83.80
-73.97
-5.01
18.57
9.98
Cash from Financing Activity
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
86.40
19.73
-192.74
-67.61
-5.25
Net Cash Inflow / Outflow
242.35
-395.41
29.02
469.12
-139.85
330.01
-68.49
169.42
94.80
153.05
Opening Cash & Equivalents
702.04
1,067.57
1,049.86
612.38
955.05
687.41
760.80
604.79
510.45
350.43
Closing Cash & Equivalent
940.06
702.04
1,067.57
1,049.86
864.95
955.05
687.41
760.80
604.79
510.45

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
279.15
273.11
257.04
206.46
147.16
112.41
84.02
70.54
60.42
49.11
ROA
3.15%
5.81%
10.28%
20.89%
11.71%
15.16%
12.79%
10.26%
12.04%
12.81%
ROE
9.34%
15.12%
23.80%
57.92%
34.19%
39.94%
33.25%
25.84%
29.15%
31.20%
ROCE
9.75%
13.81%
20.36%
45.63%
26.98%
35.06%
31.66%
23.65%
25.88%
30.26%
Fixed Asset Turnover
1.50
1.57
1.35
1.82
1.88
3.11
2.60
2.50
2.48
2.54
Receivable days
33.84
35.74
74.66
82.76
105.19
77.81
68.65
58.33
52.95
52.84
Inventory Days
49.09
57.16
90.90
66.19
81.17
84.02
82.53
70.03
68.69
55.03
Payable days
140.28
150.99
171.27
204.35
176.11
158.58
143.69
136.22
103.96
90.60
Cash Conversion Cycle
-57.35
-58.09
-5.72
-55.41
10.25
3.25
7.50
-7.86
17.68
17.27
Total Debt/Equity
1.28
1.40
0.58
0.67
1.10
0.59
0.49
0.48
0.56
0.63
Interest Cover
2.11
4.02
6.29
13.74
6.37
15.40
18.21
10.09
9.75
12.93

News Update:


  • Torrent Pharmaceuticals redeems NCDs worth Rs 240 crore
    25th Mar 2020, 10:26 AM

    The company has fully redeemed and repaid the Secured Redeemable NCDs on March 24, 2020

    Read More
  • Torrent Pharma gets shareholders' nod to raise Rs 5,000 crore via various means
    9th Mar 2020, 14:08 PM

    The approval of the shareholders was sought by way of special resolution through a postal ballot

    Read More
  • Torrent Pharma to raise Rs 5,000 crore through various means
    28th Jan 2020, 09:36 AM

    The Board of Directors of the Company at its meeting held on January 27, 2020 has approved the same

    Read More
  • Torrent Pharma planning to raise funds through various ways
    16th Jan 2020, 10:09 AM

    The Board of Directors of the Company at its meeting to be held on January 27, 2020 to consider the same

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.